After several cycles of lab testing on test animals, a medication can enter clinical trials for evaluation in humans. In phase one clinical trial testing:
A) the trial is expanded to include a large sample size, usually in the thousands of individuals, and establish the overall safety and effectiveness of the drug.
B) the medication is compared to other medications on the market.
C) consists of the drug being tested on a small number (usually 300 or less) of people with the illness or condition the drug is designed to treat.
D) researchers attempt to determine the safe dose and how the medication is both absorbed and eliminated from the body.
D
You might also like to view...
You are assessing a female patient who informs you that she has been pregnant four times before but only delivered once. Which one of the following shows how you should document that information on the prehospital care report?
A) Para IV; Gravida I B) Gravida III; Para I C) Para III; Gravida I D) Gravida IV; Para I
Protected medical information would include:
A. name and birth date of a patient. B. response time of ambulance calls. C. number of patients seen at an incident. D. number of personnel who responded to patients.